TRANSPEK
Transpek Industry financials
- Market cap
- ₹758 Cr
- Sector
- Chemicals
Quarterly results
Q1 FY27: revenue down 2.1%, net profit down 42.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 163 | 170 | 165 | 154 | 160 −1% | 158 −7% | 148 −10% | 151 −2% |
| EBITDA | 23 | 24 | 32 | 24 | 27 +18% | 25 +4% | 18 −45% | 20 −16% |
| Net profit | 10 | 11 | 19 | 16 | 13 +32% | 11 +2% | 7 −66% | 9 −43% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +18.3% YTD
YTD: ₹1,136.82 on 20 Apr 2026 → ₹1,344.9. High ₹1,446.5 (4 Sept 2026), low ₹967.45 (14 Jul 2026).
Financials, as filed
Revenue grew 3.5% a year over 2 years, FY24 to FY26. Operating margin widened to 15.0%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹580 Cr | ₹650 Cr | ₹621 Cr |
| Operating profit | ₹82 Cr | ₹95 Cr | ₹93 Cr |
| Operating margin | 14.2% | 14.6% | 15.0% |
| Interest | ₹14 Cr | ₹12 Cr | ₹8 Cr |
| Depreciation | ₹38 Cr | ₹50 Cr | ₹49 Cr |
| Net profit | ₹39 Cr | ₹49 Cr | ₹46 Cr |
| Net margin | 6.7% | 7.5% | 7.3% |
| Cash from operations | ₹98 Cr | ₹135 Cr | ₹78 Cr |
| Free cash flow | ₹60 Cr | ₹116 Cr | ₹41 Cr |
| ROCE | 9.0% | 10.0% | 8.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr | ₹6 Cr |
| Reserves | ₹374 Cr | ₹479 Cr | ₹581 Cr | ₹668 Cr | ₹762 Cr | ₹762 Cr |
| Borrowings | ₹111 Cr | ₹137 Cr | ₹145 Cr | ₹123 Cr | ₹41 Cr | ₹74 Cr |
| Other liabilities | ₹109 Cr | ₹143 Cr | ₹155 Cr | ₹169 Cr | ₹191 Cr | ₹166 Cr |
| Total liabilities | ₹599 Cr | ₹764 Cr | ₹887 Cr | ₹966 Cr | ₹1.0k Cr | ₹1.0k Cr |
| Fixed assets | ₹287 Cr | ₹295 Cr | ₹365 Cr | ₹397 Cr | ₹342 Cr | ₹343 Cr |
| Capital work in progress | ₹14 Cr | ₹16 Cr | ₹24 Cr | ₹6 Cr | ₹13 Cr | ₹5 Cr |
| Investments | ₹142 Cr | ₹196 Cr | ₹238 Cr | ₹321 Cr | ₹335 Cr | ₹316 Cr |
| Other assets | ₹156 Cr | ₹258 Cr | ₹260 Cr | ₹242 Cr | ₹310 Cr | ₹344 Cr |
| Total assets | ₹599 Cr | ₹764 Cr | ₹887 Cr | ₹966 Cr | ₹1.0k Cr | ₹1.0k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, the public added +1.00 pp while DIIs trimmed −0.78 pp.
- Promoters
- 57.3%
- FIIs
- 0.0%
- DIIs
- 1.1%
- Public
- 41.6%
Since Jun 2025
- Public +1.00 pp
- DIIs −0.78 pp
- Promoters −0.19 pp
How it drifted, 12 quarters
Over this window the public went from 38.9% to 41.6% — +2.8 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 57.5%, FIIs 1.9%, DIIs 1.8%, Public 38.9%.Dec '23: Promoters 57.5%, FIIs 0.9%, DIIs 1.8%, Public 39.8%.Mar '24: Promoters 57.5%, FIIs 0.1%, DIIs 1.8%, Public 40.7%.Jun '24: Promoters 57.5%, FIIs 0.1%, DIIs 1.8%, Public 40.7%.Sep '24: Promoters 57.5%, FIIs 0.1%, DIIs 1.9%, Public 40.6%.Dec '24: Promoters 57.5%, FIIs 0.0%, DIIs 1.9%, Public 40.6%.Mar '25: Promoters 57.5%, FIIs 0.0%, DIIs 1.9%, Public 40.6%.Jun '25: Promoters 57.5%, FIIs 0.0%, DIIs 1.8%, Public 40.6%.Sep '25: Promoters 57.5%, FIIs 0.0%, DIIs 1.6%, Public 40.9%.Dec '25: Promoters 57.5%, FIIs 0.0%, DIIs 1.6%, Public 40.9%.Mar '26: Promoters 57.5%, FIIs 0.0%, DIIs 1.6%, Public 40.9%.Jun '26: Promoters 57.3%, FIIs 0.0%, DIIs 1.1%, Public 41.6%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Transpek Industry Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Anshul Specialty Molecules Private Limited | 24.64% | unchanged |
| Kamaljyot Investments Limited | 12.58% | unchanged |
| Ashwin Champraj Shroff | 10.75% | unchanged |
| Dipkanti Investments And Financing Private Limited | 3.65% | unchanged |
| Mukul Mahavir Agrawal | 2.12% | unchanged |
| Finquest Securities Private Limited - Proprietary Account | 1.80% | unchanged |
| Madison Investments Private Limited | 1.31% | unchanged |
| Gaurav Naresh Lodha | 1.21% | unchanged |
| Minal Bharat Patel | 1.10% | unchanged |
| Unifi Financial Pvt Ltd | 1.06% | unchanged |
| Preeti Dipesh Shroff | 0.91% | unchanged |
| Upl Limited | 0.74% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
ExpensiveTo justify its price of ₹1345, this stock must grow earnings at 17% every year for 7 years. Our analysis caps realistic growth at ~9%. At that growth it is worth ₹859 — downside of 36%.
- Growth the price implies
- 17.3% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 8.8% a year
- net profit, FY24–FY26 · EPS 8.8%
- The gap
- 0.1 pp
- -36% downside if it only repeats history
Learn to analyse Transpek Industry Limited
Guides on how to read this kind of business and the numbers that matter.